Issued 10 May 2017Notice for • Designated Individuals (DIs) in the Human Application (HA) sector ScopeThis alert is being issued by the Human Tissue Authority (HTA) and includes information relevant to DIs of establishments which use human albumin during the processing of tissues or cells for human application. Please circulate this information to staff within your...
What satellite premises are and who is responsible for managing any HTA-licensed satellite premises.
Notice for Designated Individuals in the Human application sector regarding the Hepatitis C virus total antibody kit manufactured by Abbott GmbH & Co. KG and distributed in the UK by Abbott Diagnostics_x000D_ _x000D_
New guidance on completing an HTA Preparation Process Dossier
The Regulatory Advice Service for Regenerative Medicine (the Advice Service) is a ‘One Stop Shop’ for research and development professionals across academia, industry and the NHS.
The standards that establishments licensed under an HTA anatomy licence should meet
Further information about the HTA licence fee
New guidance relating to consent for research relating to transplantation where donors are deceased